|
Volumn 61, Issue 14, 2001, Pages 2097-2104
|
Darbepoetin alfa
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
ERYTHROPOIETIN;
HEMOGLOBIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
UNCLASSIFIED DRUG;
ANEMIA;
CHRONIC KIDNEY DISEASE;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
DIALYSIS;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
ERYTHROPOIESIS;
HEMOGLOBIN DETERMINATION;
HUMAN;
IMMUNE RESPONSE;
IN VIVO STUDY;
INJECTION PAIN;
NONHUMAN;
PRACTICE GUIDELINE;
REVIEW;
TREATMENT OUTCOME;
|
EID: 0035211601
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-200161140-00007 Document Type: Review |
Times cited : (41)
|
References (23)
|